Jenburkt Pharma jumps by over 10%
The shares of Jenburkt Pharmaceuticals climbed by over 10% during Tuesday’s trading session after the company reported that its board will meet on September 9, 2017 to consider buyback of equity shares.
The stock was trading up by 10.59% at Rs 459.90 per share on BSE at 1237 hours. It opened at Rs 405.45 per share. It touched its intraday high and low at Rs 466 and Rs 405 per share, respectively.
The stock witnessed a spurt in volume by more than 8.88 times on Tuesday. The stock touched its 52-week high at Rs 345 per share and 52-week low at Rs 572.50 per share.
The stock had underperformed the market over the past one month till September 4, 2017, falling 14.94% compared with 1.93% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 12.11% as against Sensex’s 1.64% rise. Whereas, the scrip had outperformed the market in past one year, rising 15.90% as against Sensex’s 11.11% rise.
The stock was trading up by 10.59% at Rs 459.90 per share on BSE at 1237 hours. It opened at Rs 405.45 per share. It touched its intraday high and low at Rs 466 and Rs 405 per share, respectively.
The stock witnessed a spurt in volume by more than 8.88 times on Tuesday. The stock touched its 52-week high at Rs 345 per share and 52-week low at Rs 572.50 per share.
The stock had underperformed the market over the past one month till September 4, 2017, falling 14.94% compared with 1.93% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 12.11% as against Sensex’s 1.64% rise. Whereas, the scrip had outperformed the market in past one year, rising 15.90% as against Sensex’s 11.11% rise.
Jenburkt Pharmaceuticals is engaged in the manufacture of pharmaceutical formulations. The company offers prescription and over-the-counter drugs.
Comments
Post a Comment